Kiniksa Pharmaceuticals, Ltd. - (KNSA) Social Stream
KINIKSA PHARMACEUTICALS LTD (KNSA) Price Targets From Analysts
Use the tables below to see what analysts covering KINIKSA PHARMACEUTICALS LTD think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-28 | 3 | $37 | $26 | $30 | $13.77 | 117.86% |
| 2021-12-29 | 3 | $34 | $25.91 | $28.97 | $13.77 | 110.38% |
| 2022-02-22 | 3 | $34 | $27 | $29.666 | $13.77 | 115.44% |
| 2022-05-03 | 3 | $28 | $24 | $25.666 | $13.77 | 86.39% |
| 2022-08-03 | 3 | $28 | $22 | $25 | $13.77 | 81.55% |
| 2022-10-31 | 3 | $28 | $19 | $24 | $13.77 | 74.29% |
| 2023-02-08 | 3 | $28 | $19 | $24.333 | $13.77 | 76.71% |
| 2023-02-28 | 2 | $28 | $19 | $24.333 | $13.77 | 76.71% |
| 2023-03-03 | 2 | $28 | $19 | $22.333 | $13.77 | 62.19% |
| 2023-05-02 | 3 | $28 | $20 | $22.666 | $13.77 | 64.6% |
| 2023-05-09 | 3 | $28 | $20 | $23 | $13.77 | 67.03% |
The Trend in the Analyst Price Target
Over the past 36 months, KNSA's average price target has gone down $7.
KNSA reports an average of 89.38% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-04 | 3 | 28 | 19 | 24.333 | 13.895 | 75.12% |
| 2023-01-27 | 3 | 28 | 19 | 24.333 | 13.990 | 73.93% |
| 2023-02-28 | 2 | 28 | 19 | 24.333 | 12.860 | 89.21% |
| 2023-03-03 | 2 | 28 | 19 | 22.333 | 12.280 | 81.86% |
| 2023-03-10 | 3 | 28 | 20 | 22.666 | 11.990 | 89.04% |
KNSA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
KNSA's average broker recommendation rating improved by 0 over the prior 34 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KNSA as an investment opportunity.
- In the context of all US stocks, KINIKSA PHARMACEUTICALS LTD's number of analysts covering the stock is greater than 90.36% of them.
- In the context of Pharmaceutical Products stocks, KINIKSA PHARMACEUTICALS LTD's variance in analysts' estimates is lower than -130.91% of them.
- KNSA has a greater average analyst price target than 773.22% of stocks in the small market cap category.
- KINIKSA PHARMACEUTICALS LTD's upside potential (average analyst target price relative to current price) is greater than 439.22% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KINIKSA PHARMACEUTICALS LTD are SLGL, EVLO, and COGT.
View All Top Stocks by Price Target
Is KNSA a Buy, Hold or Sell? See the POWR Ratings now!